Catheter Precision, Inc. reported that a group of investment funds and related managers collectively hold a significant passive stake in its common stock. The largest reported holder, Jonathan Juchno, beneficially owns 205,591 shares, representing 9.6% of the outstanding common stock. Other reporting persons include C/M Capital Master Fund, WVP Emerging Manager Onshore Fund, C/M Capital Partners, Mercer Street Global Opportunity Fund, Mercer Street Capital Partners, and Thomas Walsh, with individual stakes ranging from 2.6% to 6.4%. The ownership percentages are based on 2,131,563 shares of common stock outstanding as of the reference date. The filers certify that the securities were acquired and are held without the purpose or effect of changing or influencing control of Catheter Precision.
Positive
None.
Negative
None.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
Catheter Precision, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
74933X708
(CUSIP Number)
02/06/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
SCHEDULE 13G
CUSIP No.
74933X708
1
Names of Reporting Persons
C/M Capital Master Fund, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
82,237.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
82,237.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
82,237.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.9 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP No.
74933X708
1
Names of Reporting Persons
WVP Emerging Manager Onshore Fund LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
54,824.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
54,824.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
54,824.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
2.6 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
74933X708
1
Names of Reporting Persons
C/M Capital Partners, LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
137,061.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
137,061.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
137,061.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.4 %
12
Type of Reporting Person (See Instructions)
PN
SCHEDULE 13G
CUSIP No.
74933X708
1
Names of Reporting Persons
Mercer Street Global Opportunity Fund, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
68,530.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
68,530.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
68,530.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.2 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
74933X708
1
Names of Reporting Persons
Mercer Street Capital Partners, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
68,530.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
68,530.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
68,530.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
3.2 %
12
Type of Reporting Person (See Instructions)
OO
SCHEDULE 13G
CUSIP No.
74933X708
1
Names of Reporting Persons
Thomas Walsh
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
137,061.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
137,061.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
137,061.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
6.4 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
CUSIP No.
74933X708
1
Names of Reporting Persons
Jonathan Juchno
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
205,591.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
205,591.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
205,591.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
9.6 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
Catheter Precision, Inc.
(b)
Address of issuer's principal executive offices:
1670 Highway 160 West, Suite 205, Fort Mill, SC 29708
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) C/M Capital Master Fund, LP, a Delaware limited partnership ("C/M Master Fund");
(ii) WVP Emerging Manager Onshore Fund LLC, Delaware limited liability company ("WVP Fund");
(iii) C/M Capital Partners, LP, a Delaware limited partnership ("C/M Capital Partners");
(iv) Mercer Street Global Opportunity Fund, LLC, a Delaware limited liability company ("Mercer Fund," together with C/M Master Fund and WVP Fund, the "Funds");
(v) Mercer Street Capital Partners, LLC, a Delaware limited liability company ("Mercer Capital Partners");
(vi) Thomas Walsh ("Mr. Walsh"); and
(vii) Jonathan Juchno ("Mr. Juchno").
The foregoing persons are hereinafter sometimes collectively referred to as the "Reporting Persons."
The shares of common stock, par value $0.0001 per share (the "Common Stock") of Catheter Precision, Inc. (the "Issuer") reported herein are held by the Funds. C/M Capital Partners is the investment manager to C/M Master Fund and WVP Fund. Mercer Capital Partners is the investment manager to Mercer Fund. Messrs. Walsh and Juchno are the managing members of the general partner of C/M Capital Partners. Mr. Juchno controls Mercer Capital Partners. Messrs. Walsh and Juchno disclaim beneficial ownership of any shares of Common Stock held by the Funds.
(b)
Address or principal business office or, if none, residence:
The address of the business office of each of the Reporting Persons is 1111 Brickell Ave, Suite 2920, Miami, FL 33131.
(c)
Citizenship:
Each of C/M Master Fund and C/M Capital Partners is a limited partnership organized under the laws of the State of Delaware. Each of WVP Fund, Mercer Fund, and Mercer Capital Partners is a limited liability company organized under the laws of the State of Delaware. Each of Messrs. Walsh and Juchno is a citizen of the United States.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP No.:
74933X708
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Item 4(a) is set forth in Row 9 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
The percentages set forth in this Schedule 13G are calculated based upon an aggregate of 2,131,563 shares of Common Stock outstanding, which is the sum of (i) 1,738,955 shares of Common Stock outstanding as of February 6, 2026, as reported in Exhibit 10.1 to the Company's Current Report on Form 8-K (the "Company's 8-K") filed with the Securities and Exchange Commission on February 6, 2026 and (ii) 392,608 shares of Common Stock issued in the private placement as described in the Company's 8-K.
(b)
Percent of class:
9.6%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row 5 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row 6 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row 7 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row 8 of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
Not Applicable
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
C/M Capital Master Fund, LP
Signature:
/s/ Thomas Walsh
Name/Title:
By: C/M Global GP, LLC, General Partner, By: Thomas Walsh, Manager
Date:
02/13/2026
WVP Emerging Manager Onshore Fund LLC
Signature:
/s/ Thomas Walsh
Name/Title:
By: Cavalry Fund I GP LLC, General Partner, By: Thomas Walsh, Manager
Date:
02/13/2026
C/M Capital Partners, LP
Signature:
/s/ Thomas Walsh
Name/Title:
Thomas Walsh, Partner
Date:
02/13/2026
Mercer Street Global Opportunity Fund, LLC
Signature:
/s/ Jonathan Juchno
Name/Title:
By: NFSO, LLC, its General Partner, By: Jonathan Juchno, Authorized Representative
What ownership stake in Catheter Precision (VTAK) is reported in this Schedule 13G?
The filing reports a 9.6% beneficial ownership stake in Catheter Precision common stock. This percentage is based on 205,591 shares attributed to Jonathan Juchno, calculated against 2,131,563 shares of common stock outstanding as of the referenced date.
Who are the main reporting persons in Catheter Precision (VTAK)'s Schedule 13G?
The main reporting persons are several funds and managers, including C/M Capital Master Fund, WVP Emerging Manager Onshore Fund, and Mercer Street Global Opportunity Fund. Individuals Thomas Walsh and Jonathan Juchno are also reporting persons tied to the investment manager entities.
How many Catheter Precision (VTAK) shares does Jonathan Juchno beneficially own?
Jonathan Juchno is reported to beneficially own 205,591 shares of Catheter Precision common stock. This holding represents 9.6% of the company’s outstanding common shares, based on a total of 2,131,563 shares outstanding used for the percentage calculation.
What is C/M Capital Partners’ reported position in Catheter Precision (VTAK)?
C/M Capital Partners is reported to beneficially own 137,061 shares of Catheter Precision common stock. This position represents 6.4% of the outstanding common stock, with shared voting and dispositive power over these shares as disclosed in the ownership table.
Are the Catheter Precision (VTAK) shares held directly by Thomas Walsh and Jonathan Juchno?
The shares are held by investment funds, not directly by Walsh and Juchno. The filing explains that the common stock is held by the funds, and Walsh and Juchno disclaim beneficial ownership of shares held by those funds despite their management roles.
Is the reported Catheter Precision (VTAK) stake intended to influence control of the company?
The filing states the securities were not acquired to change or influence control of Catheter Precision. The certification confirms the holdings are passive and not part of any transaction aimed at altering control, aside from activities related to director nominations under applicable rules.
